Amit Bhanvadia, MD
Gastroenterology · Anaheim, CANPI 1861751083
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 237 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations.
Across 237 payments — averaging $23.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$683
- Gilead$571
- Conmed Corporation$351
- Pfizer$335
- Bristol Myers Squibb$331
- plus $2K from 20 others
Across 471 payments — averaging $3596.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$666K
- Boehringer Ingelheim International GmbH$323K
- AstraZeneca$240K
- Regeneron$149K
- Bausch Health US, LLC$105K
- Bristol Myers Squibb$92K
- plus $118K from 4 others
What the payments were for
- Food & beverage$5,476100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 57 | $1,278 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 36 | $683 |
| Gilead | 22 | $571 |
| Conmed Corporation | 1 | $351 |
| Pfizer | 16 | $335 |
| Bristol Myers Squibb | 25 | $331 |
| Johnson & Johnson | 10 | $253 |
| Redhill Biopharma Inc. | 12 | $229 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $181 |
| QOL Medical, LLC | 9 | $177 |
| E.r. Squibb & Sons, L.L.C. | 1 | $135 |
| Ardelyx, Inc. | 6 | $135 |
| Janssen Research & Development, LLC | 1 | $122 |
| Intercept Pharmaceuticals, Inc. | 6 | $122 |
| Nestle Healthcare Nutrition Inc. | 6 | $121 |
| Sanofi | 4 | $105 |
| Ironwood Pharmaceuticals, Inc | 5 | $94 |
| Enterra Medical, Inc. | 1 | $58 |
| Boston Scientific | 1 | $39 |
| Braintree Laboratories, Inc. | 2 | $36 |
| Lilly USA, LLC | 1 | $26 |
| Shire North American Group Inc | 1 | $25 |
| Celltrion USA Inc. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Evoke Pharma, Inc. | 1 | $15 |
| Intra-sana Laboratories | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CONMED BILIARY$351
- CONMED HEMOSTASIS$351
- CONMED GENERATORS$351
- Epclusa$112
How this compares
$5,476 in reported general payments places this provider in the 70th percentile of 1,885 gastroenterology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 17 | $287 |
| Famotidine | 13 | $67 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Anaheim
- Bennett RothLos Angeles$2.8M
- Douglas NguyenMission Viejo$2M
- Sammy SaabLos Angeles$1.9M
- Kenneth ChangNewport Beach$1.3M
- Joo HwangStanford$1M
- Drew SchembreWalnut Creek$659K
- Quan Nhula Jolla$641K
- Sadeea AbbasiLos Angeles$556K
- Ali RezaieWest Hollywood$519K
- Kenneth BinmoellerSan Francisco$507K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.